Rivastigmine USP Related Compound B with CAS No: 25081-93-0 is an impurity standard of Rivastigmine. Rivastigmine is a medication used in the treatment of Alzheimers disease and Parkinsons disease-related dementia. Structurally, it is a carbamate derivative. Rivastigmine belongs to the class of acetylcholinesterase inhibitors, and its primary mechanism of action involves increasing levels of acetylcholine, a neurotransmitter involved in cognitive function, by inhibiting its breakdown. This is particularly beneficial in conditions where there is a deficiency of acetylcholine, as seen in Alzheimers and Parkinsons disease-related dementia. Rivastigmine is available in various formulations, including oral capsules and transdermal patches, allowing for flexibility in administration. Buy high quality Rivastigmine USP Related Compound B from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of Rivastigmine USP Related Compound B
Rivastigmine USP Related Compound B
CAT. No.
CP-R27015
CAS. No.
25081-93-0
Mol. F.
C13H20N2O2
Mol. Wt.
236.32
Stock Status
Custom Synthesis
Category:
Impurity Standards
Synonyms:
N-Desethyl N-Methyl rac-Rivastigmine
Chemical Name:
(RS)-3-[1-(Dimethylamino)ethyl]phenyl dimethylcarbamate.(as per USP)
Request for Quotation : Rivastigmine USP Related Compound B
Search by Keywords - Buy 25081-93-0 | Purchase 25081-93-0 | Order 25081-93-0 | Enquire 25081-93-0 | Price of 25081-93-0 | 25081-93-0 Cost | 25081-93-0 Supplier | 25081-93-0 Distributor | 25081-93-0 Manufacturer | 25081-93-0 Exporter | Rivastigmine USP Related Compound B for Method Validation | Rivastigmine USP Related Compound B for ANDA Filing | Rivastigmine USP Related Compound B for Forced Degradation Studies | Rivastigmine USP Related Compound B Identification Standards | Rivastigmine USP Related Compound B for DMF Filing | Rivastigmine
We have received your request successfully. Thank you for your interest in our product line. To
provide you with a Quotation, Our Sales team will contact you shortly.
Chemicea Pharmaceuticals Pvt. Ltd.
Thank You
You will receive blog content, featuring scientific research and exclusive promotions.